CV Sciences reaches preliminary settlement of six derivative lawsuits; court grants approval

CV Sciences, Inc.

Court granted preliminary approval on Sept 21, 2022; final hearing set for Nov 14, 2022.
Settlement includes $275,000 in attorneys' fees to plaintiffs and corporate governance reforms.
Defendants deny all wrongdoing; settlement is not an admission of liability.
Six derivative actions consolidated: Depoti, Radcliffe, Tarangelo, Francis, Berry, Menna.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.